Sofinnova Partners
Sofinnova launches digital medicine strategy
Life sciences sponsorтs sixth strategy will deploy EUR 2m-EUR 8m tickets in seed and Series A
Apollo buys minority stake in life sciences investor Sofinnova
Deal gives the French VC firm EUR 1bn in commitments for future funds as well as access to broader LP base
Sofinnova holds EUR 472m final close for Capital X
France-headquartered VC will continue to focus on early-stage healthcare investments
Sofinnova Crossover Fund closes on €445m
Fund focuses on investments in later-stage biopharma and medtech companies that need capital to scale up
Sofinnova, Ally Bridge lead $108m Mainstay round
Mainstay intends to use the funds to support the company's commercial launch of ReActiv8 in the US
Industrifonden leads €4.6m extended series-A for EnginZyme
Latest round brings company's total series-A funding to тЌ11m
Sofinnova, Polaris lead CHF 54m series-A for Noema
Noema plans to use the fresh capital to fund the development of its clinical-stage pipeline
Sofinnova appoints Anderson as partner
Anderson has 25 years of experience in the healthcare and life sciences industries
Aledia raises €80m in series-D led by BPI France
Funding is the first of the three tranches planned for its €120m series-D round
Sofinnova, AbbVie lead €28m series-A for Enthera
Indaco Venture Partners, JDRF T1D Fund and several Italian investors also take part in the round
Sofinnova invests €1.65m in PinCell
GP deploys capital from Sofinnova Telethon Fund, which recently held a final close on €108m
Sofinnova invests €16m in Italian biotech company Genespire
GP deploys capital from Sofinnova Telethon Fund, which targets early-stage Italian biotech companies
VC Profile: Sofinnova Partners
Managing partner Graziano Seghezzi on the firm’s fundraises, its multi-asset strategy and the European life sciences VC space
Redmile, Sofinnova invest £26.3m in Redx
Redmile has agreed to subscribe for 11.5 million new ordinary shares for 11.2 pence per share
Sofinnova hires Carroll as head of investor relations
Robert Carroll previously worked at PwC and Mercury, as well as several pharmaceutical companies
Sofinnova promotes Krel to partner
Krel joined the VC in 2013 and has worked on industrial biotech investments since then
Morningside leads €39m series-B for biotech company Inotrem
Invus, Andera Partners, Sofinnova Partners and BiomedInvest also take part in the funding round
Gimv, Sofinnova, Gilde exit Breath Therapeutics for €500m
Gimv and Sofinnova Partners co-led a 2017 €43.5m series-A for Breath Therapeutics, with participation from Gilde Helathcare
Sofinnova closes MD Start III Fund on €48m
MD Start, which is a group of three funds, was started by Sofinnova Partners in 2010
LSP et al. back $38.5m series-B for DNA Script
Illumina Ventures, M Ventures, Sofinnova, Kurma and Idinvest recommit to DNA Script
Redmile Group invests in Hookipa's €33.2m series-D
Hookipa's previous investors include Sofinnova Partners, Takeda Ventures and Forbion
US Venture, Andera lead €32m series-B for HighLife
Previous backer Sofinnova Partners and new investor Sectoral Asset Management also take part
SV, Sofinnova in $30m series-A for Sitryx
Biotech company focused on immuno-oncology and immuno-inflammation launched earlier this year
Sofinnova leads €4m seed round for Enthera
JDRF T1D Fund, managed by the Juvenile Diabetes Research Foundation, also takes part in the round